1. Home
  2. PAYS vs EOLS Comparison

PAYS vs EOLS Comparison

Compare PAYS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paysign Inc.

PAYS

Paysign Inc.

HOLD

Current Price

$8.29

Market Cap

375.7M

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.78

Market Cap

407.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYS
EOLS
Founded
2001
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
375.7M
407.0M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
PAYS
EOLS
Price
$8.29
$6.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$9.42
$15.50
AVG Volume (30 Days)
591.7K
757.7K
Earning Date
05-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
85.71
1.23
EPS
0.09
N/A
Revenue
$24,120,434.00
$297,176,000.00
Revenue This Year
$33.83
$13.27
Revenue Next Year
$14.89
$17.62
P/E Ratio
$95.11
N/A
Revenue Growth
N/A
11.61
52 Week Low
$3.08
$3.86
52 Week High
$8.88
$10.20

Technical Indicators

Market Signals
Indicator
PAYS
EOLS
Relative Strength Index (RSI) 64.85 53.05
Support Level $5.01 $6.44
Resistance Level N/A $6.95
Average True Range (ATR) 0.42 0.31
MACD 0.10 -0.03
Stochastic Oscillator 82.93 37.22

Price Performance

Historical Comparison
PAYS
EOLS

About PAYS Paysign Inc.

PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: